The Global Market for Veterinary Vaccines is Projected to Reach US$9 Billion by 2022

Rise in Responsible Pet Ownership & Focus on Antibiotics Free Meat Products Drive the Veterinary Vaccines Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Veterinary Vaccines market. The global market for Veterinary Vaccines is projected to reach US$9 billion by 2022, driven by the rise in responsible pet ownership and the ensuing importance shed on animal health and the need to reduce the use of antibiotics in food producing animals.

In the livestock industry, frequent outbreaks of diseases and the resulting financial losses caused by yield reduction, is generating increased interest in animal vaccination and immunization as a strategy for disease prevention. Vaccines provide a cost-effective means to prevent and eradicate diseases. The growing global demand for animal protein, rising concerns over zoonotic infections transmitted through contaminated food and stringent regulations curbing the use of antibiotics are major factors driving demand for animal vaccines in livestock breeding. Demand in this sector will continue to benefit from the growing role played by industrial livestock production in ensuring food security. In the pet industry, growing ownership of cats and dogs are driving demand for effective veterinary vaccines.

Manufacturers are investing massive resources into R&D projects targeted at developing effective vaccine technologies. Re-emergence of certain diseases, and emergence of new virulent  diseases such as avian influenza are pushing the need for new and technologically advanced vaccines. The market is poised to benefit from the innovative approaches to vaccine development including whole-pathogen preparations, genetically engineered organisms, naked DNA injections, vectored antigen formulations and subunit vaccines defined molecularly. R&D progress in veterinary vaccines is leading to the successful development of vaccines against a range of multicellular and protozoal, bacterial and viral pathogens. Use of nucleic acid sequencing techniques for manipulating genes and produce recombinant vaccines has transformed the vaccine technology significantly. Despite the opportunities for growth, factors such as high cost of vaccines, high maintenance of vaccines such as in their storage and increasing preference for vegetarian food in some markets will continue to pose challenges to growth.  

As stated by the new market research report on Veterinary Vaccines, Europe represents the largest market worldwide, driven by well-developed veterinary infrastructure supporting the livestock and companion animal industries. China ranks as the fastest growing market with a CAGR of 9% over the analysis period, led by rising per capita meat consumption, growing animal and public health concerns, and increase in responsible pet ownerships among the expanding base of affluent middle class population. Livestock vaccines represents the largest market segment, while companion animal vaccines ranks as the fastest growing market driven by the growing preference for animal companion among single person households, and nuclear families.

Major players covered in the report include Bayer HealthCare AG, Biogénesis Bagó, Boehringer Ingelheim GmbH, Ceva Santé Animale, Elanco Animal Health, Heska Corporation, Indian Immunologicals Ltd., Merck Animal Health, Merial Ltd., Virbac SA and Zoetis Inc.

The research report titled “Veterinary Vaccines: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets, such as the US, Europe (France, Germany, Italy, UK, Spain, and Rest of Europe), Asia-Pacific (China and Rest of Asia-Pacific), and Latin America (Brazil and Rest of Latin America). Product segments analyzed in the report include Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, and Other Livestock Vaccines). 

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.